Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments: IL-6 Receptor Inhibitors and JAK Inhibitors for Hospitalized COVID-19 Patients Receiving Corticosteroid Therapy

NCT05638932 is registered in ClinicalTrials.gov with Aetion, Inc. as lead sponsor.

NCT NCT05638932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05638932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methodologies for Observational Studies Comparing Inpatient COVID-19 Treatments: IL-6 Receptor Inhibitors and JAK Inhibitors for Hospitalized COVID-19 Patients Receiving Corticosteroid Therapy
Lead sponsor
Aetion, Inc.
Phase
Observational
Overall status
Completed
Start date
June 16, 2020
Completion date
September 25, 2023
Enrollment
1,442 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19